Seeking answers to sleep, vision and gut disorders
Increasing levels of poor sleep and sleep disorders affects at least one in five Australians, leading to an estimated $66 billion a year in lost productivity […]
Renewed focus on predicting glaucoma risk
Confirmation of 40 new genetic markers takes forward the development of the first tests to assess a person’s risk of developing glaucoma, a leading cause of […]
Top award for world-leading glaucoma research
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
$24.6m boost for medical research
From diabetes, cancer and heart disease to chronic pain and major depression, 12 new research grants announced today cap off a big year for Flinders medical […]
Gene discovery sheds light on childhood glaucoma
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.
Genetic links helpful for glaucoma treatment
The discovery of new genetic areas linked to an increased risk of glaucoma will help prevent one of the leading cause of irreversible blindness in Asia.
Higher degree research wins accolades
Research into eating, eye, sleep and autoimmune disorders were among the nine outstanding papers awarded the Flinders University Best Research Higher Degree Student publications for 2015.
The fight against dementia, cancer and eye-disease receives $5.1m funding
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.
Flinders researchers find new marker for glaucoma
A person’s chance of developing glaucoma – the leading cause of blindness worldwide – could now be easier to predict following the discovery of new disease-related genes by Flinders researchers.